WebJan 31, 2024 · France-based Biosynex has entered into a deal with U.S. company Chembio Diagnostics ( NASDAQ: CEMI) under which Biosynex will acquire Chembio for $0.45 per share in an all-cash transaction valued ... WebApr 12, 2024 · ALBIO Stock Overview. About the company. Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers medical devices for in vitro diagnosis in the form of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and …
White & Case Advises Biosynex on Merger Agreement …
WebLaboratoire Biosynex, Illkirch-Graffenstaden. 31,000 likes · 13 talking about this · 15 were here. Surveillez votre santé à domicile avec les produits Biosynex disponibles en pharmacie et parapharmaci WebFind the latest Biosynex SA (ALBIO.PA) stock quote, history, news and other vital information to help you with your stock trading and investing. siged sophia
Our Company — CSE
WebApr 13, 2024 · Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc. STRASBOURG, France, April 13, 2024 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced that Project Merci Merger Sub, Inc. … WebPrivately held Biosynex SA has agreed to acquire Chembio Diagnostics Inc (NASDAQ: CEMI) for $0.45 per share in an all-cash transaction valued at $17.2 million. WebFeb 1, 2024 · Biosynex provides pharmacies and professional healthcare settings with a diversified portfolio of rapid tests covering different market segments including infectious disease and women’s health tests, point-of … sigeduca ged